Pantak, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Pantak, Inc. makes
Pantak, Inc. manufactures external beam radiotherapy devices, including the THERAPAX SXT 150 and the THERAPAX DXT 300 Model HF-300, which are designed for high-dose rate brachytherapy treatments.
These devices are classified as Class II under FDA regulations and are supported by 510(k) clearance records. The company is based in the United States.
Catalogue
Therapax Sxt 150 Ref K971074
Regimes: 510(k) Registry: 510(k)Therapax Dxt 300 Model Hf-300 Ref K973315
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Pantak, Inc. have in the registry?
The registry currently lists 2 devices for Pantak, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Pantak, Inc.'s devices?
Among its 2 most recently registered devices, Pantak, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Pantak, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Pantak, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Pantak, Inc. in the registry?
The most recently registered devices listed for Pantak, Inc. include THERAPAX SXT 150 and THERAPAX DXT 300 MODEL HF-300.